Sowell Financial Services LLC Dexcom Inc Transaction History

Sowell Financial Services LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $1.15 Million - $1.34 Million	10,257 New	10,257 $1.32 Million
Q2 2021 Aug 05, 2021	SELL	$80.99 - $107.93 $48,998 - $65,297	-605 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$84.79 - $104.74 $29,167 - $36,030	-344 Reduced 36.25%	605 $216,000
Q4 2020 Jan 13, 2021	SELL	$78.0 - $104.5 $17,784 - $23,826	-228 Reduced 19.37%	949 $351,000
Q3 2020 Nov 12, 2020	BUY	$95.51 - $112.95 $5,730 - $6,777	60 Added 5.37%	1,177 $485,000
Q2 2020 Aug 13, 2020	BUY	$62.68 - $105.34 $43,499 - $73,105	694 Added 164.07%	1,117 $453,000
Q1 2020 May 12, 2020	SELL	$47.79 - $75.63 $4,970 - $7,865	-104 Reduced 19.73%	423 $114,000
Q4 2019 Feb 07, 2020	BUY	$36.62 - $57.29 $8,312 - $13,004	227 Added 75.67%	527 $28,000
Q3 2019 Nov 14, 2019	BUY	$35.53 - $43.8 $10,659 - $13,140	300 New	300 $45,000

1,084

352M

8.45M

5.75M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.2B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.